PRACTICE
QUESTIONS
Exercise # 33
Q1. The
peripheral conversion of levodopa to dopamine causes
a. Nausea & vomiting
b. Cardiac arrhythmias
c. Postural hypertension
d. a & b only
e. All the above
Q2. With regards to carbidopa which of the
following are correct?
a. It is a dopa decarboxylase inhibitor
b. It is necessary to give atleast 100mg per
day
c. Carbidopa in high doses can control hand
rolling tremor of parkinsons disease
d. All the above
e. a & b only
Q3. Levodopa causes which of the following side
effects?
I.
Bradycardia
II.
Postural Hypertension
III.Hematological
effects - Hemolytic anemia, leucopenia, and agranulocytosis.
a. I Only
b. III Only
c. I & II only
d. II & III only
e. All
Q4. Which of the following amino acids increase
the clinical signs of Parkinson's?
a. Methionine
b. valine
c. Phenylalanine
d. Threonoine
e. Isoleucine
Q5. Direct acting dopamine agonist function by
a. They mimic dopamine agonists and decrease
motor fluctuations
b. They may have a direct antioxidant effect
c. Unlike L dopa, dyskinesias are less common
d. All of the above
Q6. Which of the direct acting dopamine agonists
cause first dose phenomenon?
a. Ergotamine
b. Pergolide
c. Pramipexole
d. Ropinirole
e. a and b only.
Q7. Pulmonary infiltrates, erythromelalgia and
retroperitoneal fibrosis are common with
a. Direct acting D agonist
b. Levodopa
c. Seligiline
d. All of the above
e. a only
Q8. Which Parkinson's drug decreases the serum
concn of LH?
a. Bromocryptine
b. Pergolide
c. Levodopa
d. Selegiline
e. Carbidopa
Q9. With regard to Selegiline which of the
following are correct
I. A
selective inhibitor of MAO B
II. Its
site of action is CNS
III.It is
a non selective MAO Inhibitor
a. I Only
b. III Only
c. I & II only
d. II & III only
e. All
Q10. Amatadine acts by
I.
Influencing the synthesis and release of dopamine
II.
Decreasing presynaptic reuptake of dopamine
III.
Preventing the demethylaion of dopamine in the CNC
a. I Only
b. III Only
c. I & II only
d. II & III only
e. All
New Exercise will
come very soon. Keep in touch with the
website.
No comments:
Post a Comment